BAVA:CPH
Bavarian Nordic A/S
DKK 221.60
arrow_downward
-0.36%(-0.80) 1D
Oct 6, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BAVA...
Open
DKK 225.00
High
DKK 228.40
Low
DKK 221.60
Mkt. cap
17.18B
Avg. vol.
168.09K
Volume
0.00
52-wk high
DKK 243.70
52-wk low
DKK 171.30
Shares outstanding
79.27M
No. of employees
2K
Open
DKK 225.00
High
DKK 228.40
Low
DKK 221.60
Mkt. cap
17.18B
Avg. vol.
168.09K
Volume
0.00
52-wk high
DKK 243.70
52-wk low
DKK 171.30
Shares outstanding
79.27M
No. of employees
2K
News stories
From web sources and news partners
marketscreener.com
·
19 minutes ago
US stocks rally as S&P 500, Nasdaq reach record closing highs
Traders Union
·
45 minutes ago
Tom McClellan: SP500 annualized returns may differ in coming decade
TradingView
·
1 hour ago
S&P 500 And Nasdaq 100 Soar To Record Highs Amid Rising Bets Of Strong Quarterly Earnings — CEG, LCID, SPCX, MRVL In Focus
ChartMill
·
4 hours ago
Uncover the latest developments among S&P500 stocks in today's session.
Profile
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
About Bavarian Nordic A/S
CEOPaul Chaplin
Employees1.91K
FoundedJul 1, 1992
Headquarters-
SectorBiotechnology
Websitebavarian-nordic.com